{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T15:58:44Z","timestamp":1772639924232,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04024-5","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:58:42Z","timestamp":1763135922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mechanism of METTL14-mediated RAD21 mRNA epigenetic transcriptome modification in inhibiting thyroid cancer development"],"prefix":"10.1186","volume":"23","author":[{"given":"Yinzhe","family":"Ge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"4","key":"4024_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","volume":"10","author":"M Pizzato","year":"2022","unstructured":"Pizzato M, Li M, Vignat J, et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 2022;10(4):264\u201372.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"4024_CR2","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1055\/a-1089-7870","volume":"52","author":"KA Araque","year":"2020","unstructured":"Araque KA, Gubbi S, Klubo-Gwiezdzinska J. Updates on the management of thyroid cancer. Horm Metab Res. 2020;52(8):562\u201377.","journal-title":"Horm Metab Res"},{"issue":"12","key":"4024_CR3","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","volume":"30","author":"S Filetti","year":"2019","unstructured":"Filetti S, Durante C, Hartl D, et al. Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-updagger. Ann Oncol. 2019;30(12):1856\u201383.","journal-title":"Ann Oncol"},{"key":"4024_CR4","doi-asserted-by":"publisher","first-page":"108613","DOI":"10.1016\/j.biopha.2019.108613","volume":"112","author":"T Sun","year":"2019","unstructured":"Sun T, Wu R, Ming L. The role of m6A RNA methylation in cancer. Biomed Pharmacother. 2019;112:108613.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4024_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21(1):14.","journal-title":"Mol Cancer"},{"issue":"1","key":"4024_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12943-023-01782-2","volume":"22","author":"H Zhuang","year":"2023","unstructured":"Zhuang H, Yu B, Tao D, et al. The role of m6A methylation in therapy resistance in cancer. Mol Cancer. 2023;22(1):91.","journal-title":"Mol Cancer"},{"issue":"4","key":"4024_CR7","doi-asserted-by":"publisher","first-page":"102547","DOI":"10.1016\/j.amjoto.2020.102547","volume":"41","author":"J Hou","year":"2020","unstructured":"Hou J, Shan H, Zhang Y, et al. m(6)A RNA methylation regulators have prognostic value in papillary thyroid carcinoma. Am J Otolaryngol. 2020;41(4):102547.","journal-title":"Am J Otolaryngol"},{"key":"4024_CR8","doi-asserted-by":"publisher","first-page":"611191","DOI":"10.3389\/fonc.2020.611191","volume":"10","author":"L Yang","year":"2020","unstructured":"Yang L, Wu S, Ma C, et al. RNA m(6)A methylation regulators subclassify luminal subtype in breast cancer. Front Oncol. 2020;10:611191.","journal-title":"Front Oncol"},{"issue":"1","key":"4024_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13045-022-01231-5","volume":"15","author":"Q Guan","year":"2022","unstructured":"Guan Q, Lin H, Miao L, et al. Functions, mechanisms, and therapeutic implications of METTL14 in human cancer. J Hematol Oncol. 2022;15(1):13.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"4024_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12943-022-01521-z","volume":"21","author":"HN Fan","year":"2022","unstructured":"Fan HN, Chen ZY, Chen XY, et al. METTL14-mediated m(6)A modification of circORC5 suppresses gastric cancer progression by regulating miR-30c-2-3p\/AKT1S1 axis. Mol Cancer. 2022;21(1):51.","journal-title":"Mol Cancer"},{"key":"4024_CR11","doi-asserted-by":"crossref","unstructured":"Singh P, Neumann DM. Cohesin subunit Rad21 binds to the HSV-1 genome near CTCF insulator sites during latency in vivo. J Virol. 2021;95(11):e00364-21.","DOI":"10.1128\/JVI.00364-21"},{"key":"4024_CR12","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3389\/fmicb.2019.01370","volume":"10","author":"M Pareek","year":"2019","unstructured":"Pareek M, Almog Y, Bari VK, et al. Alternative functional rad21 paralogs in fusarium oxysporum. Front Microbiol. 2019;10:1370.","journal-title":"Front Microbiol"},{"issue":"5","key":"4024_CR13","doi-asserted-by":"publisher","first-page":"e19470","DOI":"10.1371\/journal.pone.0019470","volume":"6","author":"A Nitzsche","year":"2011","unstructured":"Nitzsche A, Paszkowski-Rogacz M, Matarese F, et al. RAD21 cooperates with pluripotency transcription factors in the maintenance of embryonic stem cell identity. PLoS ONE. 2011;6(5):e19470.","journal-title":"PLoS ONE"},{"key":"4024_CR14","doi-asserted-by":"publisher","first-page":"144966","DOI":"10.1016\/j.gene.2020.144966","volume":"758","author":"H Cheng","year":"2020","unstructured":"Cheng H, Zhang N, Pati D. Cohesin subunit RAD21: from biology to disease. Gene. 2020;758:144966.","journal-title":"Gene"},{"issue":"36","key":"4024_CR15","doi-asserted-by":"publisher","first-page":"e2405543121","DOI":"10.1073\/pnas.2405543121","volume":"121","author":"XA Su","year":"2024","unstructured":"Su XA, Stopsack KH, Schmidt DR, et al. RAD21 promotes oncogenesis and lethal progression of prostate cancer. Proc Natl Acad Sci U S A. 2024;121(36):e2405543121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4024_CR16","doi-asserted-by":"publisher","first-page":"11738","DOI":"10.1038\/s41598-023-38923-y","volume":"13","author":"N Albarakati","year":"2023","unstructured":"Albarakati N, Al-Ghamdi H, Al-Sowayan B, et al. Homologous recombination mRNAs (RAD21, RAD50 and BARD1) have a potentially poor prognostic role in ERBB2-low bladder cancer patients. Sci Rep. 2023;13(1):11738.","journal-title":"Sci Rep"},{"issue":"15","key":"4024_CR17","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.7150\/thno.35219","volume":"9","author":"X Su","year":"2019","unstructured":"Su X, Shen Z, Yang Q, et al. Vitamin C kills thyroid cancer cells through ROS-dependent Inhibition of MAPK\/ERK and PI3K\/AKT pathways via distinct mechanisms. Theranostics. 2019;9(15):4461\u201373.","journal-title":"Theranostics"},{"issue":"1","key":"4024_CR18","doi-asserted-by":"publisher","first-page":"2419990","DOI":"10.1080\/07853890.2024.2419990","volume":"56","author":"BT Zhang","year":"2024","unstructured":"Zhang BT, Li Y, Jiang QL, et al. Human adipose-derived stem cells promote migration of papillary thyroid cancer cell via leptin pathway. Ann Med. 2024;56(1):2419990.","journal-title":"Ann Med"},{"issue":"6","key":"4024_CR19","doi-asserted-by":"publisher","first-page":"777","DOI":"10.4149\/neo_2023_230103N4","volume":"70","author":"X Yang","year":"2023","unstructured":"Yang X, Zhang M, Xia W, et al. CHAC1 promotes cell ferroptosis and enhances radiation sensitivity in thyroid carcinoma. Neoplasma. 2023;70(6):777\u201386.","journal-title":"Neoplasma"},{"issue":"2","key":"4024_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J, Yue Y, Han D, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10(2):93\u20135.","journal-title":"Nat Chem Biol"},{"issue":"4","key":"4024_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.62347\/JEIV8228","volume":"17","author":"X Han","year":"2024","unstructured":"Han X, Liao J, Zhou Y, et al. Thyroid cancer prognostic biomarker ARL4A and its relationship with immune infiltration. Int J Clin Exp Pathol. 2024;17(4):108\u201320.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"4024_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/COC.0000000000001048","volume":"47","author":"J Li","year":"2024","unstructured":"Li J, Li Z, Zhao P. Diagnosis and prognosis of thyroid cancer by Immune-related genes. Am J Clin Oncol. 2024;47(1):1\u201310.","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"4024_CR23","doi-asserted-by":"publisher","first-page":"e13168","DOI":"10.1111\/cpr.13168","volume":"55","author":"X Liu","year":"2022","unstructured":"Liu X, Du Y, Huang Z, et al. Insights into roles of METTL14 in tumors. Cell Prolif. 2022;55(1):e13168.","journal-title":"Cell Prolif"},{"issue":"8","key":"4024_CR24","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.7150\/jca.82158","volume":"14","author":"CL Sun","year":"2023","unstructured":"Sun CL, Chen J, Xing ZW, et al. METTL14 suppresses cancer stem cell phenotype of colorectal cancer via regulating of beta-catenin\/NANOG. J Cancer. 2023;14(8):1407\u201316.","journal-title":"J Cancer"},{"issue":"1","key":"4024_CR25","doi-asserted-by":"publisher","first-page":"2349429","DOI":"10.1080\/15384047.2024.2349429","volume":"25","author":"L Li","year":"2024","unstructured":"Li L, Zeng J, He S, et al. METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer. Cancer Biol Ther. 2024;25(1):2349429.","journal-title":"Cancer Biol Ther"},{"issue":"13","key":"4024_CR26","doi-asserted-by":"publisher","first-page":"7239","DOI":"10.1093\/nar\/gkab378","volume":"49","author":"S Oerum","year":"2021","unstructured":"Oerum S, Meynier V, Catala M, et al. A comprehensive review of m6A\/m6Am RNA methyltransferase structures. Nucleic Acids Res. 2021;49(13):7239\u201355.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4024_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12943-020-01220-7","volume":"19","author":"X Chen","year":"2020","unstructured":"Chen X, Xu M, Xu X, et al. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Mol Cancer. 2020;19(1):106.","journal-title":"Mol Cancer"},{"key":"4024_CR28","doi-asserted-by":"publisher","first-page":"101987","DOI":"10.1016\/j.mcp.2024.101987","volume":"78","author":"M Zhou","year":"2024","unstructured":"Zhou M, Zhang Y, Zhang Q, et al. METTL14-mediated m6A modification upregulated SOCS3 expression alleviates thyroid cancer progression by regulating the JAK2\/STAT3 pathway. Mol Cell Probes. 2024;78:101987.","journal-title":"Mol Cell Probes"},{"issue":"1","key":"4024_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12943-022-01634-5","volume":"21","author":"B Shi","year":"2022","unstructured":"Shi B, Liu WW, Yang K, et al. The role, mechanism, and application of RNA methyltransferase METTL14 in Gastrointestinal cancer. Mol Cancer. 2022;21(1):163.","journal-title":"Mol Cancer"},{"key":"4024_CR30","doi-asserted-by":"crossref","unstructured":"Allegri L, Baldan F, Molteni E, et al. Role of m6A RNA methylation in thyroid cancer cell lines. Int J Mol Sci. 2022;23(19):11516.","DOI":"10.3390\/ijms231911516"},{"issue":"1","key":"4024_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13046-022-02321-5","volume":"41","author":"M Di Nardo","year":"2022","unstructured":"Di Nardo M, Pallotta MM, Musio A. The multifaceted roles of cohesin in cancer. J Exp Clin Cancer Res. 2022;41(1):96.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4024_CR32","doi-asserted-by":"publisher","first-page":"13035","DOI":"10.1038\/s41598-022-15081-1","volume":"12","author":"W Schierding","year":"2022","unstructured":"Schierding W, Horsfield JA, O\u2019Sullivan J. Genetic variation as a long-distance modulator of RAD21 expression in humans. Sci Rep. 2022;12(1):13035.","journal-title":"Sci Rep"},{"key":"4024_CR33","doi-asserted-by":"publisher","first-page":"936550","DOI":"10.3389\/fonc.2022.936550","volume":"12","author":"R Gou","year":"2022","unstructured":"Gou R, Li X, Dong H, et al. RAD21 confers poor prognosis and affects ovarian cancer sensitivity to Poly(ADP-Ribose)Polymerase inhibitors through DNA damage repair. Front Oncol. 2022;12:936550.","journal-title":"Front Oncol"},{"key":"4024_CR34","doi-asserted-by":"crossref","unstructured":"Zhu T, Gao Z, Yuan K et al. High expression of RAD21 predicts poor survival in patients with operated non-small-cell lung cancer. Tumori. 2020:300891620910805.","DOI":"10.1177\/0300891620910805"},{"issue":"6","key":"4024_CR35","first-page":"e41119","volume":"15","author":"J Pimentel Campillo","year":"2023","unstructured":"Pimentel Campillo J, Corona Castillo D, Nunez M, et al. Pneumonia-Induced thyroid crisis with thyrotoxicosis exacerbation: de Novo graves\u2019 disease presentation on a Cornelia de Lange syndrome (CdLS). Cureus. 2023;15(6):e41119.","journal-title":"Cureus"},{"key":"4024_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2147\/JHC.S447915","volume":"11","author":"JS Pang","year":"2024","unstructured":"Pang JS, Bai XM, Wan WJ, et al. RAD21: A key transcriptional regulator in the development of residual liver cancer. J Hepatocell Carcinoma. 2024;11:285\u2013304.","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"4024_CR37","doi-asserted-by":"publisher","first-page":"42","DOI":"10.62347\/THJB4749","volume":"15","author":"LG Yang","year":"2025","unstructured":"Yang LG, Yang ZG, Zhang J, et al. Effects of (131)I and TSH suppression therapy on METTL3, METTL14 levels and recurrence in thyroid cancer. Am J Cancer Res. 2025;15(1):42\u201358.","journal-title":"Am J Cancer Res"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04024-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04024-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04024-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T01:04:12Z","timestamp":1763168652000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-04024-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4024"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04024-5","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants signed the written informed consent. This study was conducted following the Helsinki Declaration and approved by the Ethics Committee of Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University (Approval Number: Run Run Shaw Hospital Review 2023 Study No. 0213). All animal experiments were reviewed and got approval from the Animal Ethics Committee of Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University (Approval Number: Run Run Shaw Hospital Review 2023 Research No. 0017).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"434"}}